BRISBANE, Calif., Oct. 20, 2017 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, Chief Executive Officer, and Sandra Gardiner, Consultant Chief Financial Officer, will present at two upcoming investor conferences:
- Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 9th at the Westin Grand Central in New York, NY at 4:00 pm Eastern Time
- Stifel 2017 Healthcare Conference on Tuesday, November 14th at the Lotte New York Palace Hotel, New York, NY at 11:45 am Eastern Time
A live audio webcast and slides of the presentation will be made available at the Investor Relations section of the Company’s website, www.cutera.com following each presentation.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS:
Cutera, Inc.
Sandra Gardiner
Consultant Chief Financial Officer
[email protected]
415-657-5500
Investor Relations
John Mills
Integrated Corporate Relations, Inc.
646-277-1254
[email protected]


Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 



